PPBT Purple Biotech Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Purple Biotech Corp (PPBT) - korporativ logo

Robotlashtirilgan dori vositalarini skrining qilish xarajatlarni optimallashtiradi, shu sababli joriy parametr 0.13 ga tengdir. Bozor qiymatining kitob qiymatiga nisbatan tarixiy ko'rsatkichlari barqaror yon tomonga yo'naltirilgan tendentsiyani namoyish etmoqda. Purple Biotech (PPBT) moliyaviy barqarorligi CM24 patentlariga egaligi va klinik sinovlarni tashqi hamkorlarga samarali autsorsing qilishiga asoslangan bo'lib, bu operatsion risklarni minimallashtiradi va kompaniyaning kapitalini mustahkamlaydi.

Purple Biotech (PPBT) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

PPBT (Purple Biotech Ltd): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Purple Biotech|PPBT - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Purple Biotech Corp|PPBT - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Purple Biotech|PPBT - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati purple-biotech.com|PPBT - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Purple Biotech|PPBT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Purple Biotech Corp|PPBT - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Purple Biotech Corp
Fundamental baholash:PPBT (Purple Biotech)
Purple Biotech Ltd tayyor mahsulotlari

Ushbu ko'rsatkich biznesning joriy bozor qiymatini uning sof aktivlari bilan solishtiradi. Hisob-kitoblar bozorning haqiqiy kapitalga nisbatan kelajakdagi o'sish istiqbollari uchun to'lashga tayyor bo'lgan premiumini ochib beradi. Bozor qiymatining buxgalteriya qiymatiga nisbati tahlili Purple Biotech (PPBT) ning virtuallashtirilgan rivojlanish modeliga nisbatan investorlar kutganlarini aks ettiradi. CMO saytlari orqali tarqatilgan ishlab chiqarish kapital xarajatlarini minimallashtirib, baholash e'tiborini intellektual mulkka ko'chiradi. Metrikaning yuqori qiymatlari klinik sinovlarning muvaffaqiyati bo'yicha ortiqcha umidlarni signalizatsiya qiladi.

Asosiy raqobatchilar

ONC - Kapitallashuvning sof aktivlarga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIT|CVM - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ostherapies.com OSTX|Kapitallashuvning sof aktivlarga nisbati RADX (Radiopharm Theranostics)|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adlai Nortye Limited (ANL)|VERU: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Tempest Therapeutics (TPST)|XLO (Xilio Therapeutics) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Renovaro Biosciences|Bozor qiymatining balans qiymatiga nisbati Mural Bio|Kairos Pharma Ltd - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti onkuretherapeutics.com OKUR|Kapitallashuvning sof aktivlarga nisbati CytoMed Therapeutics Limited|Balans qiymatiga nisbatan bozor qiymati Curis Inc. CRIS|APLM - Bozor kapitallashuvining balans qiymatiga nisbati|THAR - Bozor qiymatining balans qiymatiga nisbati|advanbiomed.com - Bozor kapitallashuvining balans qiymatiga nisbati|GNPX (Genprex Inc) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati CLDI (Calidi Biotherapeutics Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti sunshinebiopharma.com (SBFM)|Kapitallashuvning sof aktivlarga nisbati Xenetic Biosciences|Bozor kapitallashuvining balans qiymatiga multiplikatori Salarius Pharmaceuticals Inc (SLRX)|AONC: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti BeiGene Ltd BGNE|CKPT: Bozor kapitallashuvining balans qiymatiga nisbati|ELEV - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati icadmed.com ICAD|IKNA (Ikena Oncology) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc. NTBL|Sof aktivlarga nisbatan bozor kapitallashuvi VIRX|MOR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati Ascentage Pharma AAPGV